Literature DB >> 28985993

Effects of engineered nanoparticles on the innate immune system.

Yuanchang Liu1, Joseph Hardie1, Xianzhi Zhang1, Vincent M Rotello2.   

Abstract

Engineered nanoparticles (NPs) have broad applications in industry and nanomedicine. When NPs enter the body, interactions with the immune system are unavoidable. The innate immune system, a non-specific first line of defense against potential threats to the host, immediately interacts with introduced NPs and generates complicated immune responses. Depending on their physicochemical properties, NPs can interact with cells and proteins to stimulate or suppress the innate immune response, and similarly activate or avoid the complement system. NPs size, shape, hydrophobicity and surface modification are the main factors that influence the interactions between NPs and the innate immune system. In this review, we will focus on recent reports about the relationship between the physicochemical properties of NPs and their innate immune response, and their applications in immunotherapy.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Engineered nanoparticle; Immune response; Immunomodulation; Immunotherapy; Physicochemical properties

Mesh:

Year:  2017        PMID: 28985993      PMCID: PMC5705289          DOI: 10.1016/j.smim.2017.09.011

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  102 in total

1.  The internalization pathway, metabolic fate and biological effect of superparamagnetic iron oxide nanoparticles in the macrophage-like RAW264.7 cell.

Authors:  Jingli Gu; Haifei Xu; Yehua Han; Wei Dai; Wei Hao; Chunyu Wang; Ning Gu; Haiyan Xu; Jimin Cao
Journal:  Sci China Life Sci       Date:  2011-09-16       Impact factor: 6.038

2.  Transfection system of amino-functionalized calcium phosphate nanoparticles: in vitro efficacy, biodegradability, and immunogenicity study.

Authors:  Babak Mostaghaci; Julia Susewind; Guido Kickelbick; Claus-Michael Lehr; Brigitta Loretz
Journal:  ACS Appl Mater Interfaces       Date:  2015-03-02       Impact factor: 9.229

Review 3.  Development of immunotoxicity testing strategies for immunomodulatory drugs.

Authors:  Thomas T Kawabata; Ellen W Evans
Journal:  Toxicol Pathol       Date:  2012-01-06       Impact factor: 1.902

4.  Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues.

Authors:  Saeid Zanganeh; Gregor Hutter; Ryan Spitler; Olga Lenkov; Morteza Mahmoudi; Aubie Shaw; Jukka Sakari Pajarinen; Hossein Nejadnik; Stuart Goodman; Michael Moseley; Lisa Marie Coussens; Heike Elisabeth Daldrup-Link
Journal:  Nat Nanotechnol       Date:  2016-09-26       Impact factor: 39.213

5.  Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions.

Authors:  Alessandro Parodi; Nicoletta Quattrocchi; Anne L van de Ven; Ciro Chiappini; Michael Evangelopoulos; Jonathan O Martinez; Brandon S Brown; Sm Z Khaled; Iman K Yazdi; Maria Vittoria Enzo; Lucas Isenhart; Mauro Ferrari; Ennio Tasciotti
Journal:  Nat Nanotechnol       Date:  2012-12-16       Impact factor: 39.213

Review 6.  Current understanding of interactions between nanoparticles and the immune system.

Authors:  Marina A Dobrovolskaia; Michael Shurin; Anna A Shvedova
Journal:  Toxicol Appl Pharmacol       Date:  2015-12-29       Impact factor: 4.219

7.  Fluorescent pegylated nanoparticles demonstrate fluid-phase pinocytosis by macrophages in mouse atherosclerotic lesions.

Authors:  Chiara Buono; Joshua J Anzinger; Marcelo Amar; Howard S Kruth
Journal:  J Clin Invest       Date:  2009-04-13       Impact factor: 14.808

8.  Regulation of Macrophage Recognition through the Interplay of Nanoparticle Surface Functionality and Protein Corona.

Authors:  Krishnendu Saha; Mehran Rahimi; Mahdieh Yazdani; Sung Tae Kim; Daniel F Moyano; Singyuk Hou; Ridhha Das; Rubul Mout; Farhad Rezaee; Morteza Mahmoudi; Vincent M Rotello
Journal:  ACS Nano       Date:  2016-04-11       Impact factor: 15.881

9.  Therapeutic siRNA silencing in inflammatory monocytes in mice.

Authors:  Florian Leuschner; Partha Dutta; Rostic Gorbatov; Tatiana I Novobrantseva; Jessica S Donahoe; Gabriel Courties; Kang Mi Lee; James I Kim; James F Markmann; Brett Marinelli; Peter Panizzi; Won Woo Lee; Yoshiko Iwamoto; Stuart Milstein; Hila Epstein-Barash; William Cantley; Jamie Wong; Virna Cortez-Retamozo; Andita Newton; Kevin Love; Peter Libby; Mikael J Pittet; Filip K Swirski; Victor Koteliansky; Robert Langer; Ralph Weissleder; Daniel G Anderson; Matthias Nahrendorf
Journal:  Nat Biotechnol       Date:  2011-10-09       Impact factor: 54.908

10.  The Effect of Superparamagnetic Iron Oxide Nanoparticle Surface Charge on Antigen Cross-Presentation.

Authors:  Yongbin Mou; Yun Xing; Hongyan Ren; Zhihua Cui; Yu Zhang; Guangjie Yu; Walter J Urba; Qingang Hu; Hongming Hu
Journal:  Nanoscale Res Lett       Date:  2017-01-19       Impact factor: 4.703

View more
  42 in total

1.  Challenges identifying efficacious miRNA therapeutics for cancer.

Authors:  Meirav Segal; Frank J Slack
Journal:  Expert Opin Drug Discov       Date:  2020-05-18       Impact factor: 6.098

2.  Artificial neural networks for the inverse design of nanoparticles with preferential nano-bio behaviors.

Authors:  Sergio A Hassan
Journal:  J Chem Phys       Date:  2020-08-07       Impact factor: 3.488

3.  Using nanoparticles for in situ vaccination against cancer: mechanisms and immunotherapy benefits.

Authors:  Michael-Joseph Gorbet; Akansha Singh; Chenkai Mao; Steven Fiering; Ashish Ranjan
Journal:  Int J Hyperthermia       Date:  2020-12       Impact factor: 3.914

4.  Macrophage activation by a substituted pyrimido[5,4-b]indole increases anti-cancer activity.

Authors:  Joseph Hardie; Javier A Mas-Rosario; Siyoung Ha; Erik M Rizzo; Michelle E Farkas
Journal:  Pharmacol Res       Date:  2019-09-10       Impact factor: 7.658

5.  Designing drug-free biodegradable nanoparticles to modulate inflammatory monocytes and neutrophils for ameliorating inflammation.

Authors:  Eiji Saito; Robert Kuo; Ryan M Pearson; Nishant Gohel; Brandon Cheung; Nicholas J C King; Stephen D Miller; Lonnie D Shea
Journal:  J Control Release       Date:  2019-02-27       Impact factor: 9.776

Review 6.  Cancer immunotherapy with immunoadjuvants, nanoparticles, and checkpoint inhibitors: Recent progress and challenges in treatment and tracking response to immunotherapy.

Authors:  Michael-Joseph Gorbet; Ashish Ranjan
Journal:  Pharmacol Ther       Date:  2019-12-19       Impact factor: 12.310

7.  Optimum Preparation Method for Self-Assembled PEGylation Nano-Adjuvant Based on Rehmannia glutinosa Polysaccharide and Its Immunological Effect on Macrophages.

Authors:  Yee Huang; Li Nan; Chenwen Xiao; Quanan Ji; Ke Li; Qiang Wei; Yan Liu; Guolian Bao
Journal:  Int J Nanomedicine       Date:  2019-11-29

Review 8.  Biocompatibility of nanomaterials and their immunological properties.

Authors:  Themis R Kyriakides; Arindam Raj; Tiffany H Tseng; Hugh Xiao; Ryan Nguyen; Farrah S Mohammed; Saiti Halder; Mengqing Xu; Michelle J Wu; Shuozhen Bao; Wendy C Sheu
Journal:  Biomed Mater       Date:  2021-03-11       Impact factor: 3.715

Review 9.  Nanodelivery of STING agonists against cancer and infectious diseases.

Authors:  Jiarong Zhou; Christian J Ventura; Ronnie H Fang; Liangfang Zhang
Journal:  Mol Aspects Med       Date:  2021-08-02

Review 10.  Non-Immunotherapy Application of LNP-mRNA: Maximizing Efficacy and Safety.

Authors:  Irena Vlatkovic
Journal:  Biomedicines       Date:  2021-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.